Search

Search Constraints

You searched for: Author/Creator Cataldo, Jason

Search Results

2. Effects of triheptanoin (UX007) in patients with long‐chain fatty acid oxidation disorders: Results from an open‐label, long‐term extension study. Issue 1 (14th September 2020)

3. Results from a 78‐week, single‐arm, open‐label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long‐chain fatty acid oxidation disorders (LC‐FAOD). Issue 1 (11th February 2019)